Comments

CASI Pharmaceuticals

CASINASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$6.22
-0.13-2.05%
Last update: 10:04 AM
15 minutes delayed
CASI Pharmaceuticals (CASI) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

CASI Pharmaceuticals (NASDAQ:CASI) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
11/12/2021CASI
CASI Pharmaceuticals
FY2021———$27.25M—$28.58MGet Alert

FAQ

Q

What is the most recent guidance for CASI Pharmaceuticals (CASI)?

A

There have been no specific sales or earnings guidance reported for CASI Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch